Theranostic nanomedicines for the treatment of cardiovascular and related diseases: current strategies and future perspectives

N Manners, V Priya, AK Mehata, M Rawat, S Mohan… - Pharmaceuticals, 2022 - mdpi.com
Cardiovascular and related diseases (CVRDs) are among the most prevalent chronic
diseases in the 21st century, with a high mortality rate. This review summarizes the various …

Nanomedicine approaches for advanced diagnosis and treatment of atherosclerosis and related ischemic diseases

B Hu, KO Boakye‐Yiadom, W Yu… - Advanced …, 2020 - Wiley Online Library
Cardiovascular diseases (CVDs) remain one of the major causes of mortality worldwide. In
response to this and other worldwide health epidemics, nanomedicine has emerged as a …

Bioactive compounds and nanodelivery perspectives for treatment of cardiovascular diseases

RK Sindhu, A Goyal, E Algın Yapar, S Cavalu - Applied Sciences, 2021 - mdpi.com
Bioactive compounds are comprised of small quantities of extra nutritional constituents
providing both health benefits and enhanced nutritional value, based on their ability to …

Nanomedicine and cardiovascular disease

JR McCarthy - Current cardiovascular imaging reports, 2010 - Springer
Nanomedicine has become an important tool in the imaging and therapy of numerous
diseases. This is due, in large part, to the ability to generate multifunctional nanoagents …

Recent developments in nanomaterials-based drug delivery and upgrading treatment of cardiovascular diseases

NA Mohamed, I Marei, S Crovella… - International Journal of …, 2022 - mdpi.com
Cardiovascular diseases (CVDs) are the leading causes of morbidity and mortality
worldwide. However, despite the recent developments in the management of CVDs, the …

Nanobased platform advances in cardiovascular diseases: Early diagnosis, imaging, treatment, and tissue engineering

L Shariati, Y Esmaeili, I Rahimmanesh… - Environmental …, 2023 - Elsevier
Cardiovascular diseases (CVDs) present a significant threat to health, with traditional
pharmaceuticals for their treatment being hindered by inefficiencies due to non-targeted …

[HTML][HTML] Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approaches

J Bejarano, M Navarro-Marquez, F Morales-Zavala… - Theranostics, 2018 - ncbi.nlm.nih.gov
Cardiovascular diseases are the leading cause of death worldwide. Despite preventive
efforts, early detection of atherosclerosis, the common pathophysiological mechanism …

Nanomaterials-based imaging diagnosis and therapy of cardiovascular diseases

Y Zhong, X Zeng, Y Zeng, L Yang, J Peng, L Zhao… - Nano Today, 2022 - Elsevier
Cardiovascular diseases refer to a group of the circulatory system disorders, including
atherosclerosis, thrombosis, myocardial/cerebral infarction and the following ischemia …

[HTML][HTML] Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective

A Nakhlband, M Eskandani, Y Omidi, N Saeedi… - BioImpacts …, 2018 - ncbi.nlm.nih.gov
An external file that holds a picture, illustration, etc. Object name is bi-8-59-g004. jpg
Introduction: Cardiovascular diseases (CVDs) is recognized as the leading cause of …

Nanomedicine for Diagnosis and Treatment of Atherosclerosis

J Cheng, H Huang, Y Chen, R Wu - Advanced Science, 2023 - Wiley Online Library
With the changing disease spectrum, atherosclerosis has become increasingly prevalent
worldwide and the associated diseases have emerged as the leading cause of death. Due …